ChineseInvestors.com, Inc. (CIIX) Getting Some Skin in the

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
276
ChineseInvestors.com, Inc. (CIIX) Getting Some Skin in the Game

- Entering $30+ billion Chinese skin care market
- First and only CBD-based products to market
- Expects to capture huge share of new skin care products category

Any dispute over the efficacy of medical cannabis is settled science. Recent prestigious clinical studies have provided conclusive evidence that medical cannabinoids are effective medicine for a variety of diseases and ailments (http://nnw.fm/QWn8r). Cannabidiol (CBD) has been scientifically shown to be effective in the treatment of certain epilepsies, pain, inflammation and nausea, as well as providing relief from hangover, anxiety and stress.

It comes as little surprise then that cannabis may well possess skin healing properties. Cannabis is a known anti-inflammatory containing antioxidant and anti-aging elements. Hemp seed oil contains omega-3 and omega-6 fatty acids. These essential fatty acids can enhance complexion by improving the skin’s texture and softness. They keep skin cells moist by reducing the amount of water lost through the epidermis, and they also increase production of collagen, a protein that makes up connective tissue and is a structural building block of firm, healthy skin. The human endocannabinoid system utilizes multiple cannabinoid receptors, and a large number of these are actually found in the skin.

In spite of vast anecdotal evidence, hard science has not yet settled on the positive effects of CBD skin care. However, it took decades and overcoming wrong-headed preconceptions to scientifically prove the medical efficacy of CBD in multiple maladies. It should easily follow that there are underlying benefits of topical cannabis-based skin care products.

When looking for opportunity in this new arena, look to China, the second-largest consumer of skin care products in the world, generating nearly $30 billion in annual retail sales. The recent article “Investment Options in the Multi-Billion Dollar Medical Marijuana Industry” (http://nnw.fm/Zmj4K) highlighted ChineseInvestors.com (OTCQB: CIIX) entering the multi-billion Chinese skin care industry with the introduction of a new line of cannabidiol-based skin care products. The company has filed a record of its first line of hemp-infused skin care products with the China Food and Drug Administration (http://nnw.fm/3nlZM) and expects to launch in the next couple months.

As the company stated in its press release, “Although ancient Chinese recognized the medicinal properties of the cannabis plant, CBD extract appears to be largely unrecognized in China today for its benefits, including but not limited to, its potential benefits to the largest visible human organ, the skin.”

When one considers how prevalent skin conditions are, it becomes clear that a safe, effective new treatment is likely to be embraced by a significant portion of the population. Understandably, the market potential is enormous. Not only is the market potential huge, the company anticipates capturing “100% of China’s market share in this novel skin care products category,” since, to its knowledge, no other manufacturers have entered the cannabis skin care product market in China.

Given the immense opportunity in CBD-based skin care and the multiple markets and products that ChineseInvestors.com is pursuing, it very well may be time to get some skin in the game.

For more information, visit the company’s website at www.ChineseInvestors.com

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

Chineseinvestors.com Inc. (CIIX) Stock Research Links

CIIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Actinium Pharma Unveils Plans at Key Investor Conference

Updated Category News Views 2

Actinium Pharmaceuticals Steps into the Spotlight Alright, folks, here we have Actinium Pharmaceuticals, Inc. gearing up to make some noise at the H.C. Wainwright 28th Annual Global Investment Conference. This isn't just any roadshow—it's a chance to showcase the kind of pioneering work they're doing in targeted radiotherapies. With Sandesh Seth, the Chairman, taking...

Continue Reading
Dr. Rashedi Reveals Laughing Gas Safety for Kids

Updated Category News Views 0

Why Laughing Gas is a Game-Changer in Pediatric Dentistry You ever seen a kid freeze up like a deer in headlights at the dentist's office? I'm telling you, it's not just the sweet tooth nightmare but often the fear of that cold, intimidating chair. But let's talk about a game-changer: laughing gas or, known in the trade as nitrous oxide. Keeping Anxiety at Bay: The Role...

Continue Reading
Signant and Lothar Forge Future in Clinical Trials

Updated Category News Views 1

Breathing New Life into Clinical Trials Alright, folks, listen up. We've got a fresh collaboration cooking that could shake things up in the clinical trial sector. Signant Health, a heavyweight in clinical trial solutions, has teamed up with Lothar Medical, and they’ve hitched their wagons to launch something rather intriguing: the ALDS PRO pulmonary function tech. Let...

Continue Reading
2026 AI Talent Study Reveals Growth and Gaps

Updated Category News Views 2

Pushing Forward Yet Stumbling on the Details We've got a fresh scoop from the AI Leaders Council: They just rolled out their 2026 Corporate AI Talent Study. What's the big fuss? Well, they're tracking how companies are cozying up to artificial intelligence. Let's just say it's a mixed bag this time around. While almost everyone jumped on the AI bandwagon, only a scant 3%...

Continue Reading
Virterion Surges Ahead in VPS Racing With Reliable Hosting

Updated Category News Views 1

Why Virterion Stands Out in 2026 VPS Landscape For anyone knee-deep in the hosting game, you know the market's got more players than a late-night poker round. Virterion, though—that's a name carving out a noticeable niche, and for solid reasons. In 2026, the backdrop's not just speed, it’s about matching technology and support with what ambitious developers need. VPS...

Continue Reading
Patented Foodservice Firm's $1.6M Sale: High ROI Potential

Updated Category News Views 0

Cooking Up High Margins and Rapid Growth You don’t stumble on opportunities like this every day. A foodservice company out there is posting some mouth-watering numbers, and it’s shaking up the M&A scene. This one’s got patents holding up its brand like a culinary force field, and it’s now on the auction block for a cool $1.6 million. And the numbers? Well, they...

Continue Reading
XCOTTON Shines at IFA 2026: The New Horizon of Commerce

Updated Category News Views 1

Shifting Gears at the Checkout Counter Let's face it, we've all been there: you click, you pay, and then you wait. But what happens next is where brands often drop the ball. Sure, e-commerce has been all about getting us to trust the 'buy' button. That's where folks like XCOTTON are stepping up to the plate, giving us something else to consider. They were loud and clear...

Continue Reading
Dreame Unveils Vast AI Product Range at IFA 2026

Updated Category News Views 0

Overnight Sensation or Future Staple? I wonder if Dreame's top brass woke up sweating or smiling after their big reveal at IFA 2026. A buffet of over 100 products across 16 categories is no small feat, especially when you're banking on technologies developed over nine years. But let's cut through the noise—does this showcase promise innovation or just smoke and mirrors?...

Continue Reading
Inturai Ventures Closes Final Tranche with a Twist

Updated Category News Views 4

Wrapping Up a Wild Ride in the Investment Arena Markets are a fickle friend, and today we've got Inturai Ventures calling it a day on their latest cash grab. They've locked the final tranche of their private placement, pulling in an aggregate $963,713.70. Feels like they're counting pennies in this venture, but every cent counts when your aim is to shake up industries...

Continue Reading
AVEX Faces Lawsuit Over IPO Missteps

Updated Category News Views 3

Legal Storm Brewing with AEVEX's IPO Disclosures Whatever happened to straightforward honesty in business? AEVEX Corp. (NYSE: AVEX) might have forgotten that chapter judging by fresh allegations in their midst. Investors who bought AVEX Class A common stock between April 17 and June 4, 2026, have been hit with a curveball: a looming class action lawsuit for securities...

Continue Reading
ing Brands Faces Legal Probe; Fiduciary Duties Questioned"> Continue Reading